Stay updated with breaking news from Berman Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shares of Stem, Inc. (NYSE:STEM – Get Free Report) have received a consensus rating of “Hold” from the fourteen analysts that are presently covering the firm, MarketBeat reports. One equities research analyst has rated the stock with a sell recommendation, eight have given a hold recommendation and five have issued a buy recommendation on the […]
StockNews.com initiated coverage on shares of Cytosorbents (NASDAQ:CTSO – Free Report) in a research note issued to investors on Thursday morning. The firm issued a hold rating on the medical research company’s stock. Separately, HC Wainwright restated a neutral rating and set a $1.00 target price on shares of Cytosorbents in a report on Friday, […]
Stem (NYSE:STEM – Free Report) had its target price decreased by BMO Capital Markets from $2.50 to $1.85 in a research note released on Friday morning, Benzinga reports. BMO Capital Markets currently has a market perform rating on the stock. Several other brokerages have also weighed in on STEM. TD Cowen dropped their price objective […]
StockNews.com started coverage on shares of Cytosorbents (NASDAQ:CTSO – Free Report) in a report published on Thursday morning. The firm issued a hold rating on the medical research company’s stock. Separately, HC Wainwright reissued a neutral rating and set a $1.00 price target on shares of Cytosorbents in a report on Friday, March 15th. View […]
StockNews.com initiated coverage on shares of Cytosorbents (NASDAQ:CTSO – Free Report) in a research report released on Thursday morning. The brokerage issued a hold rating on the medical research company’s stock. Separately, HC Wainwright reaffirmed a neutral rating and set a $1.00 price target on shares of Cytosorbents in a research report on Friday, March […]